NDC properties for "ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection" (RxCUI 1659592)
About this data
The tables show NDC propoerties for ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection with the RxCUI 1659592
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection (RxCUI 1659592)
| ANDA | ANDA065176 |
|---|---|
| ANDA | ANDA065222 |
| ANDA | ANDA065310 |
| ANDA | ANDA065406 |
| ANDA | ANDA090340 |
| ANDA | ANDA090349 |
| ANDA | ANDA090579 |
| ANDA | ANDA201024 |
| ANDA | ANDA201406 |
| MMSL_CODE | BD1345 |
| MMSL_CODE | CD1345 |
| RxCUI | 1659592 |
| SNOMEDCT | 370418003 |
| SPL_SET_ID | 006f9a3f-b4e3-4aa5-ac65-6cc3d3e2582d |
| SPL_SET_ID | 16fdfdb9-9e26-48d0-8838-570d30c8e897 |
| SPL_SET_ID | 1e5004f1-e79e-4e0b-9f3f-25f6bbc15255 |
| SPL_SET_ID | 4446d4c8-056d-4bc3-8f58-21255b063398 |
| SPL_SET_ID | 7161f386-6373-4db5-8dfd-d7ddf38ec2f1 |
| SPL_SET_ID | 9a722de6-9dc0-4fb9-b63a-225385aa3314 |
| SPL_SET_ID | a67ae347-487d-4751-a841-b321e81db26f |
| SPL_SET_ID | ac6f8158-9d7e-4b99-af3c-0407c5287b57 |
| SPL_SET_ID | adc92303-b62b-41c8-becf-9c3a4e8c3a6b |
| SPL_SET_ID | bb78b01f-b235-4a3e-b3d2-24543d3fd56c |
| SPL_SET_ID | d3026cc0-95d8-44cf-be47-b5ebb8fd4568 |
| SPL_SET_ID | d4e9ca30-7af3-42ec-e053-2995a90afe1f |
| SPL_SET_ID | dc374fa4-350b-425d-a7db-7099fdc64cf1 |
| SPL_SET_ID | e6cf14a8-3ed9-4a7a-ba69-be0b794cbdc4 |
| VUID | 4008598 |
| Prescribable Synonym | ampicillin / sulbactam 1.5 GM Injection |
| RXNAV_STR | ampicillin 1000 MG / sulbactam 500 MG Injection |
| RxNorm Name | ampicillin 1000 MG / sulbactam 500 MG Injection |
| RxNorm Synonym | ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection |
| RxNorm Synonym | ampicillin 1 GM / sulbactam 0.5 GM Injection |
| Related queries | Interactions (for RxCUI 1659592) |
NDC Properties
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| Packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
| Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 67457-348 |
NDC Item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| Packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82449-513 |
NDC Item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |
NDC Item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| Packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83634-109 |